Zepp Health CORP

Form 420-F13G

Insider Trading (Form 4)

NYSE
Pengtao Yu, Chief Industrial Designer of Zepp Health Corp, sold 10,000 shares of common stock on September 23, 2026.
NYSE
Zepp Health Corp's Chief Technology Officer, Meihui Fan, acquired 520,000 Class A ordinary shares and was granted multiple option tranches on June 26, 2026.
NYSE
Zepp Health Corp's Chief Financial Officer, Cheng Deng, sold a portion of American Depositary Shares to cover tax obligations following the vesting of restricted share units.

Schedule 13G - Passive Investments

See all →
NYSE
Millennium Management and affiliated entities have filed a Schedule 13G amendment, reporting no beneficial ownership of Zepp Health Corporation's Class A Ordinary Shares.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.8% of Zepp Health Corp's Class A Ordinary Shares/ADRs.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.8% of Zepp Health Corp's Class A Ordinary Shares/ADRs.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has disclosed beneficial ownership of 8.5% of Zepp Health Corp's Class A Common Stock as of June 30, 2026.
NYSE
Morgan Stanley has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Zepp Health Corp.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has reported beneficial ownership of 10.0% of Zepp Health Corp's Class A Common Stock as of March 31, 2026.